48
Views
2
CrossRef citations to date
0
Altmetric
Review

RNA-based therapeutic strategies for cancer

, , , &
Pages 627-638 | Published online: 02 Mar 2005
 

Abstract

Recent progress in the field of RNA therapeutics has highlighted the potential of using RNA-based strategies for the treatment of human cancer. Emerging technologies such as small interfering RNA (siRNA) to trigger RNA interference (RNAi) and catalytic RNA molecules, called ribozymes, are being developed to modulate expression of genes to either block tumourigenesis itself, inhibit tumour growth or prevent metastasis. Delivery of mRNA or vectors based on positive-strand RNA viruses such as alpha viruses, picornaviruses and flaviviruses have also found applications in the development of cancer vaccines and for apoptosis of tumour cells. These approaches should help overcome some of the drawbacks of viral vectors used in the majority (~ 60%) of clinical trials for cancer gene therapy, including potential malignant transformation due to insertional mutagenesis with retroviral delivery and pre-existing immune responses to adenoviral proteins. In this review, the advantages and disadvantages of RNA-based therapeutic strategies and their potential use in cancer treatments will be compared.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.